BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23379343)

  • 1. HIV vaccine development: strategies for preclinical and clinical investigation.
    Shapiro SZ
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1401-6. PubMed ID: 23379343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical development of candidate HIV vaccines: different problems for different vaccines.
    Shapiro SZ
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):325-9. PubMed ID: 24168166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New directions for HIV vaccine development from animal models.
    McChesney MB; Miller CJ
    Curr Opin HIV AIDS; 2013 Sep; 8(5):376-81. PubMed ID: 23836045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadly neutralizing antibodies and vaccine design against HIV-1 infection.
    Wang Q; Zhang L
    Front Med; 2020 Feb; 14(1):30-42. PubMed ID: 31858368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in mucosal HIV vaccine development: lessons from non-human primate models.
    Tuero I; Robert-Guroff M
    Viruses; 2014 Aug; 6(8):3129-58. PubMed ID: 25196380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses.
    Ringel O; Vieillard V; Debré P; Eichler J; Büning H; Dietrich U
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29662026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on clinical development of candidate HIV vaccines: different problems for different vaccines.
    McMichael A; Dorrell L
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):331-2. PubMed ID: 24606555
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on Shapiro: clinical development of candidate HIV vaccines: different problems for different vaccines.
    Hope TJ; Betts MR
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):330. PubMed ID: 24620907
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel approaches in preclinical HIV vaccine research.
    Safrit JT; Koff WC
    Curr Opin HIV AIDS; 2016 Nov; 11(6):601-606. PubMed ID: 27636502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing T Follicular Helper Cell Responses for HIV Vaccine Development.
    Niessl J; Kaufmann DE
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29921828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective.
    Staprans SI; Feinberg MB; Shiver JW; Casimiro DR
    Curr Opin HIV AIDS; 2010 Sep; 5(5):377-85. PubMed ID: 20978377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.
    Hope TJ; Marrazzo JM
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1055-9. PubMed ID: 26486613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in HIV vaccines inducing mucosal immune responses.
    Pavot V; Rochereau N; Lawrence P; Girard MP; Genin C; Verrier B; Paul S
    AIDS; 2014 Jul; 28(12):1701-18. PubMed ID: 25009956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of HIV vaccine research and the role of the Global HIV Vaccine Enterprise.
    Voronin Y; Manrique A; Bernstein A
    Curr Opin HIV AIDS; 2010 Sep; 5(5):414-20. PubMed ID: 20978383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural infection as a blueprint for rational HIV vaccine design.
    van Haaren MM; van den Kerkhof TL; van Gils MJ
    Hum Vaccin Immunother; 2017 Jan; 13(1):229-236. PubMed ID: 27649455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV vaccine: Can it be developed in the 21st century?
    Verma R; Khanna P; Chawla S; Dhankar M
    Hum Vaccin Immunother; 2016; 12(1):222-4. PubMed ID: 26212081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV research may be right on target for potential vaccine.
    Rees J
    Expert Rev Vaccines; 2013 Jul; 12(7):719. PubMed ID: 23885816
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV vaccine development: Lessons from the past, informing the future.
    Bradac J; Dieffenbach CW
    IDrugs; 2009 Jul; 12(7):435-9. PubMed ID: 19579164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in humanized mice: accelerating the development of an HIV vaccine.
    Tager AM; Pensiero M; Allen TM
    J Infect Dis; 2013 Nov; 208 Suppl 2(Suppl 2):S121-4. PubMed ID: 24151317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the science. HIV vaccine development.
    Grady C; Kelly G
    Nurs Clin North Am; 1996 Mar; 31(1):25-39. PubMed ID: 8604385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.